|An intronic polymorphism in GRP78 improves chemotherapeutic prediction in non-small cell lung cancer||Zhu, X; Lin, MCM; Fan, W; Tian, L; Wang, J; Ng, SS; Wang, M; Kung, H; Li, D||2012||50|
|Loss/down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma||Yang, G; He, W; Cai, M; Luo, F; Kung, H; Guan, X; Zeng, Y; Xie, D||2011||372|
|An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers||Zhu, X; Chen, L; Fan, W; Lin, MCM; Tian, L; Wang, M; Lin, S; Wang, Z; Zhang, J; Wang, J; Yao, H; Kung, H; Li, D||2011||54|
|Heme oxygenase-1 system and gastrointestinal inflammation: A short review||Zhu, X; Fan, WG; Li, DP; Kung, H; Lin, MCM||2011||50|
|The 3′ UTR variants in the GRP78 are not associated with overall survival in resectable hepatocellular carcinoma||Zhu, X; Wang, F; Lin, MCM; Tian, L; Fan, W; Ng, SS; Liu, M; Huang, J; Xu, Z; Li, D; Kung, H||2011||237|
|Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma||Cai, M; Zhang, B; He, W; Yang, G; Rao, H; Rao, Z; Wu, Q; Guan, X; Kung, H; Zeng, Y; Xie, D||2010||268|
|Heme oxygenase-1 system and gastrointestinal tumors||Zhu, X; Fan, WG; Li, DP; Lin, MCM; Kung, H||2010||51|
|No association between the haplotypic block in the 3′ UTR of GRP78 and risk of hepatocellular carcinoma||Zhu, X; Wang, J; Wang, Q; Zhang, Y; Chen, L; Tian, L; Shen, H; Lin, MCM; Wang, M; Xie, D; Kung, H||2010||59|
|c-jun NH2-terminal Kinase (JNK1) Upregulates XIAP-associated Factor 1 (XAF1) through Interferon Regulatory Factor 1 (IRF-1) in Gastrointestinal Cancer||Wang, J; Zhang, W; Zhang, Y; Chen, Y; Zou, B; Jiang, B; Pang, RWC; Gu, Q; Qiao, L; Lan, HY; Kung, H; Wong, BCY||2009||174|
|Makorin-2 is a Neurogenesis Inhibitor Downstream of PI3K/AKT Signal||Yang, P; Cheung, KC; Peng, Y; He, ML; Wu, G; Xie, D; Jiang, B; Huang, Q; Chen, Z; Lin, MC; Kung, H||2008||153|
|Novel interaction between xiap-associated factor 1 (XAF1) and nuclear coactivator CBP in colon cancer.
Digestive Disease Week 2006, 20-25 May, Los Angeles, USA||Sun, Y; Xia, HHX; Zhu, S; Zou, B; Lin, MC; Kung, H; Wong, BCY||2006||96|
|Interferon-β-induced expression of XAF1 requires phosphorylation of STAT1 and a sequential activation of protein kinase C and JNK in colon cancer.
Digestive Disease Week 2006, 20-25 May, Los Angeles, USA||Sun, Y; Wang, J; Xia, HHX; Zou, B; Lin, MC; Kung, H; Wong, BCY||2006||118|
|Treatment of Human and Rat Hepatocellular Carcinomas by Long Term Expression of rAAV-Mediated Transfer of Human TERTC27 Polypeptide||Lin, MC; Ng, SM; Gao, Y; Lum, CT; Yang, Z; Huang, J; Lau, G; Fan, ST; Kung, H||2005||81|
|Novel HCC gene therapy by rAAV-mediated transfer of human TERTC27 polypeptide in human and rat hepatocellular carcinoma (Abstract)||Ng, SM; Gao, Y; Lum, CT; Yang, Z; Huang, J; Lau, G; Fan, ST; Kung, H; Lin, MC||2005||235|
|rAAV-mediated long-term expression of endostatin significantly inhibits the progression of HCC (Abstract)||Ng, SM; Gao, Y; Lum, CT; Yang, Z; Lau, G; Fan, ST; Kung, H; Lin, MC||2005||109|
|Adeno-associated virus mediated long term expression of human TERTC27 polypeptide inhibited glioblastoma carcinogenesis by multiple mechanisms||Ng, SM; Gao, Y; Huang, J; Huang, C; Kung, H; Lin, MC||2005||91|
|Ascorbic acid inhibits ROS production, NF-kappaB activation and prevents enthanol-induced growth retardation and microencephaly||Peng, Y; Kwok, KH; Yang, P; Ng, SM; Liu, J; Wong, GW; He, ML; Kung, H; Lin, MC||2005||149|
|Down-regulation of XIAP associated factor 1 (XAF1) through Hsf-1 binding in the promoter region||Wang, J; Gu, Q; He, H; Jiang, B; Zhuang, Z; Xia, HHX; Lin, MC; Lam, SK; Kung, H; Wong, BCY||2005||100|
|Hypermethylation status around exon 1 of XIAP-Associated Factor 1(XAF1) in human gastric and colon cancer cell line.
Asian Pacific Digestive Week, Sept. 25-28, 2005, Seoul, Korea.||Zou, B; Lin, MC; Lam, SK; Tu, S; Zeng, H; Yang, Y; Wang, J; He, H; Jiang, SH; Kung, H; Wong, BCY||2005||127|
|Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy.||Gu, Q; Xia, HHX; Wang, J; Chan, OO; Lai, KC; Fung, FMY; Wong, KW; Cheung, KL; Kung, H; Wong, BCY||2005||94|